A dose-escalation study of urocortin 2 gene transfer (RT-200) in type 2 diabetes patients
Latest Information Update: 18 Jul 2017
At a glance
- Drugs RT 200 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; First in man
- 18 Jul 2017 New trial record
- 17 Jul 2017 Accordingt to a Renova Therapeutics media release, the company plans to conduct this study in 2018.